EPISODE · Oct 25, 2024 · 52 MIN
S2E64: Gut Vitality - Interview with Roxeanne Hardenburg
from Dream to Rise · host Cynthia Encinas-Concordia
Roxeanne Hardenburg, Founder & CEO of Essential Farmaceuticals LTD. Roxeanne is on a mission to change the narrative and redefine human healing, by empowering individuals with the tools and resources to effectively fast-track their own healing. Her work focuses on women's hormonal harmony, gut restoration, and total body synchronicity, providing a clear roadmap for individuals looking for real health results, that last. Roxanne's passion stems from personal experiences that underscored the profound impact of gut health on overall well-being. Discussing and addressing gut health is vital, it’s often the missing link in conversations about wellness. By openly exploring this topic, we can break down barriers and stigma, fostering a supportive community where healing can thrive. Together, we can embrace a path to total wellness and elevate our lives from the inside out.
What this episode covers
Roxeanne Hardenburg, Founder & CEO of Essential Farmaceuticals LTD. Roxeanne is on a mission to change the narrative and redefine human healing, by empowering individuals with the tools and resources to effectively fast-track their own healing. Her work focuses on women's hormonal harmony, gut restoration, and total body synchronicity, providing a clear roadmap for individuals looking for real health results, that last. Roxanne's passion stems from personal experiences that underscored the profound impact of gut health on overall well-being. Discussing and addressing gut health is vital, it’s often the missing link in conversations about wellness. By openly exploring this topic, we can break down barriers and stigma, fostering a supportive community where healing can thrive. Together, we can embrace a path to total wellness and elevate our lives from the inside out.
NOW PLAYING
S2E64: Gut Vitality - Interview with Roxeanne Hardenburg
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m